Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 973143, 13 pages
http://dx.doi.org/10.1155/2015/973143
Review Article

Medicinal Plants and Their Inhibitory Activities against Pancreatic Lipase: A Review

1Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2School of Biomedical Sciences, Faculty of Science, University of Nottingham Malaysia Campus, Jalan Broga, 43500 Semenyih, Selangor, Malaysia

Received 3 June 2015; Accepted 15 October 2015

Academic Editor: Vincenzo De Feo

Copyright © 2015 Atefehalsadat Seyedan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Padwal, S. K. Li, and D. C. W. Lau, “Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials,” International Journal of Obesity, vol. 27, no. 12, pp. 1437–1446, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. Billington, L. H. Epstein, N. J. Goodwin et al., “Overweight, obesity, and health risk,” Archives of Internal Medicine, vol. 160, no. 7, pp. 898–904, 2000. View at Publisher · View at Google Scholar
  3. E. Giovannucci, D. M. Harlan, M. C. Archer et al., “Diabetes and cancer: a consensus report,” CA—A Cancer Journal for Clinicians, vol. 60, no. 4, pp. 207–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Cairns, “Obesity: the fat lady sings?” Drug Discovery Today, vol. 10, no. 5, pp. 305–307, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. W. Gillman and L. Poston, Maternal Obesity, Cambridge University Press, Cambridge, UK, 2012.
  7. WHO, “Obesity and overweight,” 2014, http://www.who.int/mediacentre/factsheets/fs311/en/.
  8. A. H. Mokdad, J. S. Marks, D. F. Stroup, and J. L. Gerberding, “Actual causes of death in the United States, 2000,” The Journal of the American Medical Association, vol. 291, no. 10, pp. 1238–1245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ng, T. Fleming, M. Robinson et al., “Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 384, no. 9945, pp. 766–781, 2014. View at Google Scholar
  10. WHO, Obesity and Overweight, World Health Organization, Geneva, Switzerland, 2003.
  11. J. G. Kang and C.-Y. Park, “Anti-obesity drugs: a review about their effects and safety,” Diabetes & Metabolism Journal, vol. 36, no. 1, pp. 13–25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Glazer, “Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety,” Archives of Internal Medicine, vol. 161, no. 15, pp. 1814–1824, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Christensen, P. K. Kristensen, E. M. Bartels, H. Bliddal, and A. Astrup, “Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials,” The Lancet, vol. 370, no. 9600, pp. 1706–1713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. W. P. T. James, I. D. Caterson, W. Coutinho et al., “Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects,” The New England Journal of Medicine, vol. 363, no. 10, pp. 905–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Nisoli and M. O. Carruba, “A benefit-risk assessment of sibutramine in the management of obesity,” Drug Safety, vol. 26, no. 14, pp. 1027–1048, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Guerciolini, “Mode of action of orlistat,” International Journal of Obesity and Related Metabolic Disorders, vol. 21, supplement 3, pp. S12–S23, 1997. View at Google Scholar · View at Scopus
  17. A. Ballinger and S. R. Peikin, “Orlistat: its current status as an anti-obesity drug,” European Journal of Pharmacology, vol. 440, no. 2-3, pp. 109–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Hadvary, H. Lengsfeld, and H. Wolfer, “Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin,” Biochemical Journal, vol. 256, no. 2, pp. 357–361, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Napier and M. Thomas, “36 Year old man presenting with pancreatitis and a history of recent commencement of orlistat case report,” Nutrition Journal, vol. 5, no. 1, article 19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-P. Chaput, S. St-Pierre, and A. Tremblay, “Currently available drugs for the treatment of obesity: sibutramine and orlistat,” Mini-Reviews in Medicinal Chemistry, vol. 7, no. 1, pp. 3–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. N. M. Neary, A. P. Goldstone, and S. R. Bloom, “Appetite regulation: from the gut to the hypothalamus,” Clinical Endocrinology, vol. 60, no. 2, pp. 153–160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Chantre and D. Lairon, “Recent findings of green tea extract AR25 (exolise) and its activity for the treatment of obesity,” Phytomedicine, vol. 9, no. 1, pp. 3–8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. T. J. Atkinson, “Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy,” Obesity Reviews, vol. 9, no. 2, pp. 108–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Näslund and P. M. Hellström, “Appetite signaling: from gut peptides and enteric nerves to brain,” Physiology & Behavior, vol. 92, no. 1-2, pp. 256–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. K. G. Murphy and S. R. Bloom, “Gut hormones and the regulation of energy homeostasis,” Nature, vol. 444, no. 7121, pp. 854–859, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Kahler, M. Zimmermann, and W. Langhans, “Suppression of hepatic fatty acid oxidation and food intake in men,” Nutrition, vol. 15, no. 11-12, pp. 819–828, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. M. I. Friedman, “Obesity and the hepatic control of feeding behavior,” Drug News & Perspectives, vol. 20, no. 9, pp. 573–578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M.-P. St-Onge and P. J. H. Jones, “Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity,” The Journal of Nutrition, vol. 132, no. 3, pp. 329–332, 2002. View at Google Scholar · View at Scopus
  29. H. E. Bays, “Current and investigational antiobesity agents and obesity therapeutic treatment targets,” Obesity Research, vol. 12, no. 8, pp. 1197–1211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. M. Loftus, D. E. Jaworsky, C. L. Frehywot et al., “Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors,” Science, vol. 288, no. 5475, pp. 2379–2381, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-K. Kim, M. Della-Fera, J. Lin, and C. A. Baile, “Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes,” The Journal of Nutrition, vol. 136, no. 12, pp. 2965–2969, 2006. View at Google Scholar · View at Scopus
  32. R. J. Nicolosi, T. A. Wilson, C. Lawton, and G. J. Handelman, “Dietary effects on cardiovascular disease risk factors: beyond saturated fatty acids and cholesterol,” Journal of the American College of Nutrition, vol. 20, supplement 5, pp. 421S–427S, 2001. View at Google Scholar · View at Scopus
  33. J. Hirsch and B. Batchelor, “Adipose tissue cellularity in human obesity,” Clinics in Endocrinology and Metabolism, vol. 5, no. 2, pp. 299–311, 1976. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Barceló-Batllori and R. Gomis, “Proteomics in obesity research,” Proteomics: Clinical Applications, vol. 3, no. 2, pp. 263–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. I. Lefterova and M. A. Lazar, “New developments in adipogenesis,” Trends in Endocrinology & Metabolism, vol. 20, no. 3, pp. 107–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. R. B. Birari and K. K. Bhutani, “Pancreatic lipase inhibitors from natural sources: unexplored potential,” Drug Discovery Today, vol. 12, no. 19-20, pp. 879–889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. N. A. Lunagariya, N. K. Patel, S. C. Jagtap, and K. K. Bhutani, “Inhibitors of pancreatic lipase: state of the art and clinical perspectives,” EXCLI Journal, vol. 13, pp. 897–921, 2014. View at Google Scholar · View at Scopus
  38. M. E. Lowe, “The triglyceride lipases of the pancreas,” Journal of Lipid Research, vol. 43, no. 12, pp. 2007–2016, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Tsujita, Y. Matsuura, and H. Okuda, “Studies on the inhibition of pancreatic and carboxylester lipases by protamine,” Journal of Lipid Research, vol. 37, no. 7, pp. 1481–1487, 1996. View at Google Scholar · View at Scopus
  40. T. Tsujita, H. Takaichi, T. Takaku, S. Aoyama, and J. Hiraki, “Antiobesity action of ϵ-polylysine, a potent inhibitor of pancreatic lipase,” The Journal of lipid research, vol. 47, no. 8, pp. 1852–1858, 2006. View at Publisher · View at Google Scholar
  41. M. Sumiyoshi and Y. Kimura, “Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice,” Journal of Pharmacy and Pharmacology, vol. 58, no. 2, pp. 201–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Lairon, H. Lafont, J.-L. Vigne, G. Nalbone, J. Léonardi, and J. C. Hauton, “Effect of dietary fibers and cholestyramine on the activity of pancreatic lipase in vitro,” The American Journal of Clinical Nutrition, vol. 42, no. 4, pp. 629–638, 1985. View at Google Scholar · View at Scopus
  43. D. M. Roy and B. O. Schneeman, “Effect of soy protein, casein and trypsin inhibitor on cholesterol, bile acids and pancreatic enzymes in mice,” The Journal of Nutrition, vol. 111, no. 5, pp. 878–885, 1981. View at Google Scholar
  44. N. G. Sahib, A. A. Hamid, D. Kitts, M. Purnama, N. Saari, and F. Abas, “The effects of morinda citrifolia, momordica charantia and centella asiatica extracts on lipoprotein lipase and 3t3-l1 preadipocytes,” Journal of Food Biochemistry, vol. 35, no. 4, pp. 1186–1205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Bustanji, M. Mohammad, M. Hudaib et al., “Screening of some medicinal plants for their pancreatic lipase inhibitory potential,” Jordan Journal of Pharmaceutical Sciences, vol. 4, no. 2, pp. 81–88, 2011. View at Google Scholar · View at Scopus
  46. M. A. Ado, F. Abas, A. S. Mohammed, and H. M. Ghazali, “Anti- and pro-lipase activity of selected medicinal, herbal and aquatic plants, and structure elucidation of an anti-lipase compound,” Molecules, vol. 18, no. 12, pp. 14651–14669, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Adisakwattana, J. Intrawangso, A. Hemrid, B. Chanathong, and K. Mäkynen, “Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile acids,” Food Technology and Biotechnology, vol. 50, no. 1, pp. 11–16, 2012. View at Google Scholar · View at Scopus
  48. Y. S. Kim, Y. Lee, J. Kim et al., “Inhibitory activities of Cudrania tricuspidata leaves on pancreatic lipase in vitro and lipolysis in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 878365, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. H.-Y. Lai, S.-L. Ong, and N. K. Rao, “In vitro lipase inhibitory effect of thirty two selected plants in Malaysia,” Asian Journal of Pharmaceutical and Clinical Research, vol. 7, no. 3, 2014. View at Google Scholar · View at Scopus
  50. F. Conforti, V. Perri, F. Menichini et al., “Wild mediterranean dietary plants as inhibitors of pancreatic lipase,” Phytotherapy Research, vol. 26, no. 4, pp. 600–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. C.-D. Zheng, Y.-Q. Duan, J.-M. Gao, and Z.-G. Ruan, “Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs,” Journal of the Chinese Medical Association, vol. 73, no. 6, pp. 319–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Toma, E. Makonnen, Y. Mekonnen, A. Debella, and S. Addisakwattana, “Intestinal alpha-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 180, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. L. S. Teixeira, A. S. Lima, A. P. A. Boleti et al., “Effects of Passiflora nitida Kunth leaf extract on digestive enzymes and high caloric diet in rats,” Journal of Natural Medicines, vol. 68, no. 2, pp. 316–325, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Marrelli, M. R. Loizzo, M. Nicoletti, F. Menichini, and F. Conforti, “Inhibition of key enzymes linked to obesity by preparations from Mediterranean dietary plants: effects on α-amylase and pancreatic lipase activities,” Plant Foods for Human Nutrition, vol. 68, no. 4, pp. 340–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. A. P. Ekanem, M. Wang, J. E. Simon, and D. A. Moreno, “Antiobesity properties of two African plants (Afromomum meleguetta and Spilanthes acmella) by pancreatic lipase inhibition,” Phytotherapy Research, vol. 21, no. 12, pp. 1253–1255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Kumar, A. Karmase, S. Jagtap, R. Shekhar, and K. K. Bhutani, “Pancreatic lipase inhibitory activity of cassiamin A, a bianthraquinone from Cassia siamea,” Natural Product Communications, vol. 8, no. 2, pp. 195–198, 2013. View at Google Scholar · View at Scopus
  57. C. Roh and U. Jung, “Screening of crude plant extracts with anti-obesity activity,” International Journal of Molecular Sciences, vol. 13, no. 2, pp. 1710–1719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Kaewpiboon, K. Lirdprapamongkol, C. Srisomsap et al., “Studies of the in vitro cytotoxic, antioxidant, lipase inhibitory and antimicrobial activities of selected Thai medicinal plants,” BMC Complementary and Alternative Medicine, vol. 12, no. 1, article 217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Chompoo, A. Upadhyay, S. Gima, M. Fukuta, and S. Tawata, “Antiatherogenic properties of acetone extract of Alpinia zerumbet seeds,” Molecules, vol. 17, no. 6, pp. 6237–6248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Morikawa, S. Chaipech, H. Matsuda et al., “Anti-hyperlipidemic constituents from the bark of Shorea roxburghii,” Journal of Natural Medicines, vol. 66, no. 3, pp. 516–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. M. Lee, Y. S. Kim, Y. Lee et al., “Inhibitory activities of pancreatic lipase and phosphodiesterase from Korean medicinal plant extracts,” Phytotherapy Research, vol. 26, no. 5, pp. 778–782, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Raghavendra, N. Mallikarjun, and T. Venugopal, “Elemental composition, anticariogenic, pancreatic lipase inhibitory and cytotoxic activity of Artocarpus lakoocha Roxb pericarp,” International Journal of Drug Development and Research, vol. 4, no. 1, pp. 330–336, 2012. View at Google Scholar
  63. S. P. de Souza, L. L. S. Pereira, A. A. Souza, and C. D. dos Santos, “Inhibition of pancreatic lipase by extracts of Baccharis trimera (Less.) DC., Asteraceae: evaluation of antinutrients and effect on glycosidases,” Revista Brasileira de Farmacognosia, vol. 21, no. 3, pp. 450–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. S. A. Ivanov, K. Nomura, I. L. Malfanov, I. V. Sklyar, and L. R. Ptitsyn, “Isolation of a novel catechin from Bergenia rhizomes that has pronounced lipase-inhibiting and antioxidative properties,” Fitoterapia, vol. 82, no. 2, pp. 212–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Yoshikawa, H. Shimoda, N. Nishida, M. Takada, and H. Matsuda, “Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats,” The Journal of Nutrition, vol. 132, no. 7, pp. 1819–1824, 2002. View at Google Scholar · View at Scopus
  66. D. A. Moreno, N. Ilic, A. Poulev, D. L. Brasaemle, S. K. Fried, and I. Raskin, “Inhibitory effects of grape seed extract on lipases,” Nutrition, vol. 19, no. 10, pp. 876–879, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. D. A. Moreno, N. Ilic, A. Poulev, and I. Raskin, “Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters,” Life Sciences, vol. 78, no. 24, pp. 2797–2803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. I. K. Adnyana, E. Y. Sukandar, A. Yuniarto, and S. Finna, “Anti-obesity effect of the pomegranate leaves ethanol extract (Punicagranatuml.) in high-fat diet induced mice,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 4, pp. 626–631, 2014. View at Google Scholar · View at Scopus
  69. S. Habtemariam, “Antihyperlipidemic components of Cassia auriculata aerial parts: identification through in vitro studies,” Phytotherapy Research, vol. 27, no. 1, pp. 152–155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Han, W. Li, S. Narimatsu et al., “Inhibitory effects of compounds isolated from fruit of Juglans mandshurica on pancreatic lipase,” Journal of Natural Medicines, vol. 61, no. 2, pp. 184–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. D. A. Moreno, C. Ripoll, N. Ilic, A. Poulev, C. Aubin, and I. Raskin, “Inhibition of lipid metabolic enzymes using Mangifera indica extracts,” Journal of Food, Agriculture and Environment, vol. 4, no. 1, pp. 21–26, 2006. View at Google Scholar · View at Scopus
  72. Y. Ono, E. Hattori, Y. Fukaya, S. Imai, and Y. Ohizumi, “Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats,” Journal of Ethnopharmacology, vol. 106, no. 2, pp. 238–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Kurihara, S. Asami, H. Shibata, H. Fukami, and T. Tanaka, “Hypolipemic effect of Cyclocarya paliurus (Batal) Iljinskaja in lipid-loaded mice,” Biological and Pharmaceutical Bulletin, vol. 26, no. 3, pp. 383–385, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Y. Kim and M. H. Kang, “Screening of Korean medicinal plants for lipase inhibitory activity,” Phytotherapy Research, vol. 19, no. 4, pp. 359–361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. N. Sharma, V. K. Sharma, and S.-Y. Seo, “Screening of some medicinal plants for anti-lipase activity,” Journal of Ethnopharmacology, vol. 97, no. 3, pp. 453–456, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Gholamhoseinian, B. Shahouzebi, and F. Sharifi-far, “Inhibitory effect of some plant extracts on pancreatic lipase,” International Journal of Pharmacology, vol. 6, no. 1, pp. 18–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. C.-S. Kwon, H. Y. Sohn, S. H. Kim et al., “Anti-obesity effect of Dioscorea nipponica makino with lipase-inhibitory activity in rodents,” Bioscience, Biotechnology and Biochemistry, vol. 67, no. 7, pp. 1451–1456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Mendelsohn and M. J. Balick, “The value of undiscovered pharmaceuticals in tropical forests,” Economic Botany, vol. 49, no. 2, pp. 223–228, 1995. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Ahmadiani, M. Fereidoni, S. Semnanian, M. Kamalinejad, and S. Saremi, “Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome extract in rats,” Journal of Ethnopharmacology, vol. 61, no. 3, pp. 229–235, 1998. View at Publisher · View at Google Scholar · View at Scopus
  80. S. A. Mitchell and M. H. Ahmad, “A review of medicinal plant research at the University of the West Indies, Jamaica, 1948–2001,” West Indian Medical Journal, vol. 55, no. 4, pp. 243–269, 2006. View at Google Scholar · View at Scopus